Perrigo (PRGO) EBIT Growth (5y) (2017 - 2026)
Perrigo (PRGO) EBIT Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Perrigo | 1.98 Bn | 1.58 Bn | 313.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 16.94% |
| Mar 28, 2026 | -56.01% |
| Dec 31, 2025 | -105.03% |
| Sep 27, 2025 | -1.55% |
| Jun 28, 2025 | -6.25% |
| Mar 29, 2025 | -11.50% |
| Dec 31, 2024 | 38.45% |
| Sep 28, 2024 | 8.13% |
| Jun 29, 2024 | -19.94% |
| Mar 30, 2024 | -20.49% |
| Dec 31, 2023 | -16.49% |
| Sep 30, 2023 | 20.20% |
| Jul 1, 2023 | -9.72% |
| Apr 1, 2023 | -20.87% |
| Dec 31, 2022 | -27.85% |
| Oct 1, 2022 | -27.25% |
| Jul 2, 2022 | -15.40% |
| Apr 2, 2022 | -29.93% |
| Dec 31, 2021 | 15.96% |
| Oct 2, 2021 | 18.11% |